AGP Picks
View all

Sci-Tech North Carolina: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech North Carolina.

Press releases published on October 19, 2026

Proof and Circle Show How AI Agents Can Prove Who They Act For and Pay in USDC
NOVARC TO SHOWCASE PHYSICAL AI ON ROBOTIC WELDING SOLUTIONS AT FABTECH 2026
XBiotech Announces Positive Phase II Final Efficacy Results from Investigator-Sponsored TASKIN Trial in Refractory Metastatic Colorectal Cancer
Bill Gross, the Entrepreneur Behind 175+ Companies, Launches Idealab.ai to Give Away Millions of Business Ideas—and Help People Everywhere Build Them
BNB Standard Corporation Appoints Alex Odagiu as Chief Executive Officer and Announces Plan to Operate a BNB Chain Validator
Timeero Launches MCP Server to Bring Workforce Data Into AI Assistants
SciSparc Shifts Focus to Agentic AI, Targeting Cybersecurity and Finance Applications
Bel Fuse Schedules Third Quarter 2026 Financial Results Conference Call
NTHU Signs Exclusive Collaboration Agreement with NuCube Energy to Explore Deploying NuSun™ Microreactors for Power, Research, and Medical Applications
Supernus Pharmaceuticals to Announce Third Quarter 2026 Financial Results and Host Conference Call on October 29, 2026
Indivior to Report Third Quarter 2026 Financial Results
Wave Life Sciences to Host Virtual Research Day on Wednesday, November 4, 2026
NRx Pharmaceuticals (Nasdaq:NRXP) Announces Completion of Manufacturing Process Validation and Two-Year Stability of Preservative-Free Ketamine
Roze AI Signs MOA Targeting Approximately US$111.8 Million in AI Fire Safety and Related Project Work
Roze AI, 약 1,500억 원(US$111.8M) 목표로 AI 화재안전·관련 공사 협력 MOA 체결
Beyond Copper: Fabric.AI and Kopin Model Up to 60% Increase in GPU Utilization in a Neural I/o™-Powered Data Center
The Future of Healthcare: AI-Powered, Coordinated and Proactive Care
Alpha Tau Announces FDA Approval to Expand Alpha DaRT® U.S. Recurrent Glioblastoma REGAIN Trial; New Trial Data to be Presented at SNO 2026 Annual Meeting
Zone Frontier Inc. Announces 1-for-60 Reverse Stock Split
Enlivex Announces Cost Reduction Plan to Focus Resources on Phase 2b Trial of Allocetra™ in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Sci-Tech North Carolina

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.